1. Home
  2. VTSI vs ELOX Comparison

VTSI vs ELOX Comparison

Compare VTSI & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.15

Market Cap

51.0M

ML Signal

HOLD

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$12.94

Market Cap

43.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VTSI
ELOX
Founded
1993
N/A
Country
United States
United States
Employees
N/A
7
Industry
Miscellaneous manufacturing industries
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
43.8M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
VTSI
ELOX
Price
$3.15
$12.94
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
49.6K
44.8K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$185,971.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$10.00
52 Week High
$7.47
$15.00

Technical Indicators

Market Signals
Indicator
VTSI
ELOX
Relative Strength Index (RSI) 36.24 40.18
Support Level N/A N/A
Resistance Level $3.60 N/A
Average True Range (ATR) 0.15 2.37
MACD 0.00 -0.08
Stochastic Oscillator 2.08 51.30

Price Performance

Historical Comparison
VTSI
ELOX

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: